Literature DB >> 33346859

[Antinuclear antibodies : Practical diagnostic recommendations for dermatologists].

Bettina Santler1, Jan Ehrchen2.   

Abstract

Antinuclear antibodies (ANA) are a common diagnostic finding in patients with systemic autoimmune diseases. In patients with typical clinical symptoms, the determination of ANA is of both diagnostic and prognostic importance. However, if ANA were determined due to unspecific symptoms, the interpretation of ANA findings can be problematic. In these cases, misjudgements with severe consequences for the patients are possible. Many systemic autoimmune diseases have prominent early skin involvement and the dermatologist can be the first physician that such a patient sees. Therefore, knowledge of ANA diagnostics is important for dermatologists. Basic principles of autoantibody diagnostics, guidance for the interpretation of laboratory results and new developments are discussed in this overview.

Entities:  

Keywords:  Dermatomyositis; Laboratory diagnostics; Systemic autoimmune diseases; Systemic lupus erythematodes; Systemic sclerosis

Mesh:

Substances:

Year:  2021        PMID: 33346859     DOI: 10.1007/s00105-020-04740-x

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  2 in total

1.  Antinuclear antibodies in rosacea patients.

Authors:  Anna Woźniacka; Małgorzata Salamon; Daniel McCauliffe; Anna Sysa-Jędrzejowska
Journal:  Postepy Dermatol Alergol       Date:  2013-02-20       Impact factor: 1.837

2.  Autoantibodies in systemic autoimmune disorders.

Authors:  Michael Mahler; Silvia Pierangeli; Pier-Luigi Meroni; Marvin J Fritzler
Journal:  J Immunol Res       Date:  2014-06-30       Impact factor: 4.818

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.